Emerging Stocks Down Under 23 March 2021: Race Oncology, Family Zone Cyber Safety, Strategic Elements
Race Oncology: Racing up, but may get puffed soon
In today's edition of Emerging Stocks Down Under, in June 2020 you could get the cancer drug developer Race Oncology for just over 30 cents a share. Suddenly it went over $1.00 and even though it was back at 75 cents on 8 October, the best was yet to come. By 11 March 2021 Race Oncology had raced all the way to $4.07. Investors clearly reckon Race Oncology has an approvable drug. They might, we fear, get tired of waiting though.
Also in today's edition, a look at student and family cyber security developer Family Zone Cyber Safety (ASX: FZO) and technology incubator Strategic Elements (ASX: SOR).
Click here to read the previous edition of Emerging Stocks Down Under published 16 March 2021